Silencing of Rac1 modifies lung cancer cell migration, invasion and actin cytoskeleton rearrangements and enhances chemosensitivity to antitumor drugs.

Silencing of Rac1 modifies lung cancer cell migration, invasion and actin cytoskeleton rearrangements and enhances chemosensitivity to antitumor drugs.

Item
http://www.wikidata.org/entity/Q39491304
AXL kinase as a novel target for cancer therapyPaxillin mutations affect focal adhesions and lead to altered mitochondrial dynamics: relevance to lung cancerMyosin Light Chain Kinase: A Potential Target for Treatment of Inflammatory DiseasesHsa-microRNA-101 suppresses migration and invasion by targeting Rac1 in thyroid cancer cells.The Rac Inhibitor EHop-016 Inhibits Mammary Tumor Growth and Metastasis in a Nude Mouse Model.RAC1 inhibition as a therapeutic target for gefitinib-resistant non-small-cell lung cancerSubpathway Analysis based on Signaling-Pathway Impact Analysis of Signaling PathwayMicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.Rac1 overexpression is correlated with epithelial mesenchymal transition and predicts poor prognosis in non-small cell lung cancer.TIPE2 suppresses angiogenesis and non-small cell lung cancer (NSCLC) invasiveness via inhibiting Rac1 activation and VEGF expression.The role of Rac1 in the regulation of NF-κB activity, cell proliferation, and cell migration in non-small cell lung carcinoma.Silencing Ras-Related C3 Botulinum Toxin Substrate 1 Inhibits Growth and Migration of Hypopharyngeal Squamous Cell Carcinoma via the P38 Mitogen-Activated Protein Kinase Signaling Pathway.shRNA-induced silencing of Ras-related C3 botulinum toxin substrate 1 inhibits the proliferation of colon cancer cells through upregulation of BAD and downregulation of cyclin D1.Inhibition of the Receptor Tyrosine Kinase AXL Restores Paclitaxel Chemosensitivity in Uterine Serous Cancer.Rac1 Modulates Endothelial Function and Platelet Aggregation in Diabetes Mellitus.Invasion and replication of Yersinia ruckeri in fish cell cultures.
P2860

Silencing of Rac1 modifies lung cancer cell migration, invasion and actin cytoskeleton rearrangements and enhances chemosensitivity to antitumor drugs.

Item
http://www.wikidata.org/entity/Q39491304
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Silencing of Rac1 modifies lun ...... ensitivity to antitumor drugs.
@en
Silencing of Rac1 modifies lun ...... ensitivity to antitumor drugs.
@nl
type
label
Silencing of Rac1 modifies lun ...... ensitivity to antitumor drugs.
@en
Silencing of Rac1 modifies lun ...... ensitivity to antitumor drugs.
@nl
prefLabel
Silencing of Rac1 modifies lun ...... ensitivity to antitumor drugs.
@en
Silencing of Rac1 modifies lun ...... ensitivity to antitumor drugs.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Silencing of Rac1 modifies lun ...... ensitivity to antitumor drugs.
@en
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P921